Publication
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
Journal Paper/Review - Jul 24, 2009
Viale G, Goldhirsch A, Gelber R D, Öhlschlegel Christian, Karlsson P, Crivellari D, Golouh R, Brown R W, Price K N, Regan M M, Castiglione-Gertsch M, Colleoni M, Mallon E, Sonzogni A, Mastropasqua M G, Maiorano E, Gusterson B A, Giobbie-Hurder A, Coates A S
Viale, G
12
0
Giobbie-Hurder, A
4
0
Gusterson, B A
4
0
Maiorano, E
2
0
Mastropasqua, M G
2
0
Sonzogni, A
1
0
Mallon, E
2
0
Colleoni, M
25
0
Castiglione-Gertsch, M
25
0
Regan, M M
13
0
Price, K N
20
0
Brown, R W
2
0
Golouh, R
2
0
Crivellari, D
17
0
Karlsson, P
4
0
Öhlschlegel, Christian
40
4
Gelber, R D
40
0
Goldhirsch, A
54
0
Coates, A S
35
0